Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow

Journal of Obstetrics and Gynaecology

Volumn 28, Issue 3, 2008, Pages 285-289

  Anastasakis, E ^a,b   Papantoniou, N ^a   Daskalakis, G ^a   Mesogitis, S ^a   Antsaklis, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Doppler; IUGR; Malondialdehyde; Oxidative stress; Pre eclampsia; Uric acid; Uterine arteries

Indexed keywords

BIOLOGICAL MARKER; MALONALDEHYDE; URIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PLACENTA CIRCULATION; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; UTERINE ARTERY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; MALONDIALDEHYDE; MASS SCREENING; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PROBABILITY; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, PRENATAL; URIC ACID; UTERUS;

EID: 45749093787     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802042852     Document Type: Article

References (18)

1. Campbell S, Pearce JM, Hackett G, Cohen-Overbeek T, Hernandez C. 1986. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstetrics and Gynecology 68:649-653.
2. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ et al. 1999. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 354:810-816.
3. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS et al. 2002. A longitudinal study of biochemical variables in women at risk of preeclampsia. American Journal of Obstetrics and Gynecology 187:127-136.
4. Davey DA, MacGillivray I. 1988. The classification and definition of the hypertensive disorders of pregnancy. American Journal of Obstetrics and Gynecology 158:892-898.
5. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. 1992. Customised antenatal growth charts. Lancet 339:283-287.
6. Karatzis E, Lekakis J, Papamichael C, Andreadou I, Cimponeriu A, Aznaouridis K et al. 2005. Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina. International Journal of Cardiology 101:65-70.
7. Lewis G, Drife J, Botting B, Gordan G, Greer I, Kumar C et al. 1998. Why mothers die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-1996. Department of Health, Welsh Office, Scottish Office. Department of Health and Social Services. London: Stationery Office.
8. Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V. 2005. Prediction of preeclampsia with maternal mid-trimester placental growth factor, Activin A, fibronectin and uterine artery velocimetry. International Journal of Gynaecology and Obstetrics 89:251-257.
9. National Heart, Lung, and Blood Institute (NHLBI). 2000. Available at: http://www.nhlbi.nih.gov/health/prof/heart/hbp/hbp_preg.htm
10. Papageorgiou AT, Yu CKH, Bindra R, Pandis G, Nicolaides KH. 2001. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstetrics and Gynecology 18:441-449.
11. Parra M, Rodrigo R, Barja P, Bosco C, Fernändez V, Muñoz H et al. 2005. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. American Journal of Obstetrics and Gynecology 193:1486-1491.
12. Pilalis A, Souka A, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis et al. 2007. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound in Obstetrics and Gynecology 29:135-140.
13. Polyzos NP, Mauri D, Tsappi M, Tzioras S, Kamposioras K, Cortinovis I et al. 2007. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: A systematic review. Obstetrical and Gynecological Survey 62:202-206.
14. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH; Vitamins in Pre-eclampsia (VIP) Trial Consortium. 2006. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-control trial. Lancet 367:1145-1154.
15. Sagol S, Ozkinay E, Ozsener S. 1999. Impaired antioxidant activity in women with pre-eclampsia. International Journal of Gynecology and Obstetrics 64:121-127.
16. Sharma JB, Mittal S. 2004. Oxidative stress and pre-eclampsia. Obstetrics and Gynecology Today 9:551-554.
17. Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. 2006. Oxidative stress and antioxidant levels in normal pregnancy and pre-eclampsia. International Journal of Gynaecology and Obstetrics 94:23-27.
18. Sikkema JM, van Rijn BB, Franx A, Bruinse HW, de Roos R, Stroes ES et al. 2001. Placental superoxide is increased in pre-eclampsia. Placenta 22:304-308.